Drug Profile
Dutasteride/tamsulosin - GSK
Alternative Names: Combodart; Duodart; Jalyn; Tamsulosin/dutasterideLatest Information Update: 08 Jul 2023
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Developer GSK
- Class Amines; Antiandrogens; Azasteroids; Benzene derivatives; Ethers; Small molecules; Sulfonamides
- Mechanism of Action Alpha-1a adrenergic receptor antagonists; Cholestenone 5-alpha reductase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Benign prostatic hyperplasia
Most Recent Events
- 29 Mar 2019 Chemical structure information added
- 01 Oct 2015 GlaxoSmithKline completes a phase I pharmacokinetics trial (In volunteers) in USA (NCT02509104)
- 01 Jul 2015 GlaxoSmithKline initiates a phase I pharmacokinetics trial (In volunteers) in USA (NCT02509104)